Expression patterns of HAAO are variable among different cancer types (5, 22, 23); however, studies of endometrial carcinomas revealed promotor hypermethylation of HAAO is prominent and to be associated with microsatellite instability and poor clinical outcomes (102). The gene discussed is HAAO; the disease is endometrial carcinoma.